Genetic Signatures Limited (ASX:GSS)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Identifying Individual Genetic Signatures	19.75M	13.77M	21.51M	35.50M	28.38M
Identifying Individual Genetic Signatures Growth	43.47%	-36.00%	-39.39%	25.06%	105.43%
Total	19.75M	13.77M	21.51M	35.50M	28.38M
Total Growth	43.47%	-36.00%	-39.39%	25.06%	105.43%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
EMEA	2.91M	1.11M	1.62M	4.19M	4.45M
EMEA Growth	163.00%	-31.65%	-61.35%	-5.69%	301.72%
Eliminations	-2.55M	-382.00K	-1.31M	-3.71M	-3.24M
Asia Pacific	15.23M	9.01M	16.23M	34.80M	25.40M
Asia Pacific Growth	69.10%	-44.51%	-53.36%	37.02%	99.87%
Americas	303.00K	33.00K	393.00K	135.00K	1.68M
Americas Growth	818.18%	-91.60%	191.11%	-91.96%	55866.67%
Unallocated Other Income	3.85M	4.00M	4.57M	-	-
Unallocated Other Income Growth	-3.72%	-12.51%	-	-	-
Total	19.75M	13.77M	21.51M	35.42M	28.28M
Total Growth	43.47%	-36.00%	-39.26%	25.23%	104.70%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 17, 2026

Data Sources Report a data error